Jun 29, 2026
Jun 29, 2026
Jun 29, 2026
Jun 29, 2026
Jun 29, 2026
Jun 29, 2026
Jun 29, 2026
Jun 29, 2026
Novo Nordisk's recent moves in the anti-obesity market aim to regain ground against Eli Lilly. With new drug launches and pricing shifts, the question is whether they'll catch up.